CAS 18493-83-9

Formula: C11H10N2O2

InChI: InChI=1S/C11H10N2O2/c14-10-9(7-12-11(15)13-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H2,12,13,14,15)

InChI key: RPZOVLGFKOOIRP-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)CC2=CNC(=O)NC2=O

5-Benzylpyrimidine-2,4(1H,3H)-dione

CAS: 18493-83-9

5-Benzylpyrimidine-2,4(1H,3H)-dione

Formula: C₁₁H₁₀N₂O₂

Purity: 98%

Molecular weight: 202.21

Ref: 54-OR1061756

5-Benzylpyrimidine-2,4(1H,3H)-dione

CAS: 18493-83-9

5-Benzylpyrimidine-2,4(1H,3H)-dione

Formula: C₁₁H₁₀N₂O₂

Purity: 98%

Molecular weight: 202.21

Ref: IN-DG01564991

5-Benzyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

CAS: 18493-83-9

5-Benzyl-1,2,3,4-tetrahydropyrimidine-2,4-dione is a potent HIV replication inhibitor. It inhibits viral DNA synthesis by binding to the polymerase chain reaction (PCR) enzyme as well as to the cellular polymerase β and DNA dependent RNA polymerase. 5-Benzyl-1,2,3,4-tetrahydropyrimidine-2,4-dione has been shown to be effective in animal models of hepatitis B and C by inhibiting reverse transcription. 5BPD also has anti cancer activity against both cultured cells and animals. In vitro studies have shown that 5BPD is active against human liver cancer cell lines in addition to breast cancer cell lines. 5BPD is metabolized by hydrogen chloride and malonic acid into an intermediate which reacts with uridine monophosphate (UMP) to form a pyrimidine nucleotide analogue (NMP). This NMP

Formula: C₁₁H₁₀N₂O₂

Purity: Min. 95%

Molecular weight: 202.21 g/mol

Ref: 3D-TAA49383